Hailong Zhang

CEO

Innoxtal Therapeutics

Short Biography

Dr. Hailong Zhang, Founder and CEO of Blueray Biopharma., before Blueray, Dr. Zhang worked at Array biopharma. Inc. and Novartis, holding various management positions. Dr. Zhang has published more than 20 research articles in peer-reviewed journals, including Science and Nature. Dr. Zhang was involved in the discovery of many approved drugs such as BRAFTOVI/MEKTOVI(Pfizer), VITRAKVI (Eli Lilly), RETEVMO (Eli Lilly), GANOVO (Ascletis), KRAZATI(Mirati).

Presentation Topic:  Targeting the WD40 domain E3 ligases for TPD drug discovery
Many E3 ligases belong to WD40 protein family, Innoxtal focus on these E3 ligases, study disease link, find E3 ligases ligands, and use the ligand to design novel PROTACs for human diseases.